Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Disease Areas › Infectious Disease › FIND Joins CARB-X to Support Development of Diagnostics to Combat Antimicrobial Resistance

FIND Joins CARB-X to Support Development of Diagnostics to Combat Antimicrobial Resistance

Feb 26, 2019
|
staff reporter

NEW YORK (360Dx) – The Foundation for Innovative New Diagnostics (FIND) is joining the Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) Global Accelerator Network, the organizations announced today.

The CARB-X Global Accelerator Network now includes 10 organizations that provide business, scientific, and technical expertise and services to CARB-X-funded companies to support their antibacterial research projects.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Aug
19
Featured Webinar

Case Study: An IVD Manufacturer’s Experience Building a Complete Sample-to-Result Workflow

Sponsored by
UgenTec

This webinar will present a case study from in vitro diagnostics developer SpeeDx on its experience building a complete sample-to-result workflow — encompassing instrumentation and data analysis software — for its qPCR-based ResistancePlus MG Mycoplasma genitalium assay.

Oct
09
Featured Webinar

Navigating the FDA's EUA Process for Diagnostics in the Present and Future: A Stakeholder Panel Discussion

Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.

What's Popular?

In Infectious Disease

  1. Laboratory, Provider Organizations Urge HHS to Update COVID-19 Testing Prioritization Guidelines

  2. Sherlock Bio, Dartmouth-Hitchcock Health Partner on Clinical Study of Sherlock CRISPR SARS-CoV-2 Kit

  3. Solaris Diagnostics, Alpha Genomix Coronavirus Tests Get FDA Emergency Use Authorization

  4. What's Holding Up Home Testing for SARS-CoV-2?

    Premium

  5. FDA Sends Warning Letters About Unauthorized SARS-CoV-2 Tests

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.